AACI regularly distributes surveys to assess the needs of academic cancer centers and inform programming decisions. Survey data are aggregated and anonymized to share with respondents. In some cases, data informed by surveys are published in scientific journals that are accessible outside the AACI cancer center network. However, AACI surveys are only to be completed by cancer center members and survey respondents are not permitted to share unpublished results outside their cancer centers.
Compensation Survey
The annual Compensation Survey collects demographic and compensation data, including job title and salary, for the top-level leadership positions across AACI cancer centers. A report is provided to all responding centers following the survey.
Clinical Trials Office (CTO) Benchmarking Survey
The annual CTO Benchmarking Survey tracks cancer center CTO workload, structure, and staffing; trial activation timelines; and sources of CTO funding support.
The 2024 survey is currently open. Data from the 2023 survey were published in JCO Oncology Practice.
Read North American Cancer Center Clinical Research Capacity and Benchmarking in the Postpandemic Era
Academic Time Survey
In 2019, AACI conducted a survey assessing how protected time is provided for faculty physicians with clinical responsibilities who participate in clinical research and academic activities. In 2024, the Physician Clinical Leadership Initiative (PCLI) Steering Committee revised and redistributed the survey to gather updated protected time policies at AACI cancer centers. The survey closed in September 2024 and publication is pending.
Read the 2019 Survey Data
Compensation Survey
The annual Compensation Survey collects demographic and compensation data, including job title and salary, for the top-level leadership positions across AACI cancer centers. A report is provided to all responding centers following the survey.
Clinical Trials Office (CTO) Benchmarking Survey
The annual CTO Benchmarking Survey tracks cancer center CTO workload, structure, and staffing; trial activation timelines; and sources of CTO funding support.The survey will be disseminated in summer 2025.
Cellular Therapy Benchmarking Survey
The Cellular Therapy Initiative Steering Committee will develop a cellular therapy benchmarking survey to help centers advocate for increased funding, staff, and resources. The survey will assess number of commercial and research immune effector cellular (IEC) therapy patients managed in a 3-year period, commercial products offered, availability of educational resources for patients, and more. The survey will be disseminated in spring 2025.